Unique Severe COVID-19 Placental Signature Independent of Severity of Clinical Maternal Symptoms

被引:35
|
作者
Husen, Marjolein F. [1 ]
van der Meeren, Lotte E. [2 ,3 ]
Verdijk, Robert M. [3 ,4 ]
Fraaij, Pieter L. A. [5 ,6 ]
van der Eijk, Annemiek A. [5 ]
Koopmans, Marion P. G. [6 ]
Freeman, Liv [7 ]
Bogers, Hein [8 ]
Trietsch, Marjolijn D. [9 ]
Reiss, Irwin K. M. [10 ]
DeKoninck, Philip L. J. [1 ]
Schoenmakers, Sam [1 ]
机构
[1] Univ Med Ctr, Dept Obstet & Gynaecol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[2] Leiden Univ Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands
[3] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands
[4] Univ Med Ctr, Dept Pathol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[5] Univ Med Ctr, Dept Virosci, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
[6] Erasmus MC, Dept Pediat Infectiol Immunol & Rheumatol, NL-3015 GD Rotterdam, Netherlands
[7] Ikazia Hosp, Dept Obstet & Gynaecol, NL-3083 AN Rotterdam, Netherlands
[8] Franciscus Vlietland Hosp, Dept Obstet & Gynaecol, NL-3045 PM Rotterdam, Netherlands
[9] Leiden Univ Med Ctr, Dept Obstet & Gynaecol, NL-2333 ZA Leiden, Netherlands
[10] Univ Med Ctr, Dept Neonatol, Erasmus MC, NL-3015 GD Rotterdam, Netherlands
来源
VIRUSES-BASEL | 2021年 / 13卷 / 08期
关键词
placenta; SARS-CoV-2; pregnancy; foetal outcome; UNKNOWN ETIOLOGY; CHRONIC INTERVILLOSITIS; REPRODUCIBILITY; INFLAMMATION; INFECTION; PATHOLOGY; NOSOLOGY; VILLITIS; LESIONS; WOMEN;
D O I
10.3390/v13081670
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Although the risk for transplacental transmission of SARS-CoV-2 is rare, placental infections with adverse functional consequences have been reported. This study aims to analyse histological placental findings in pregnancies complicated by SARS-CoV-2 infection and investigate its correlation with clinical symptoms and perinatal outcomes. We want to determine which pregnancies are at-risk to prevent adverse pregnancy outcomes related to COVID-19 in the future. Methods: A prospective, longitudinal, multicentre, cohort study. All pregnant women presenting between April 2020 and March 2021 with a nasopharyngeal RT-PCR-confirmed SARS-CoV-2 infection were included. Around delivery, maternal, foetal and placental PCR samples were collected. Placental pathology was correlated with clinical maternal characteristics of COVID-19. Results: Thirty-six patients were included, 33 singleton pregnancies (n = 33, 92%) and three twin pregnancies (n = 3, 8%). Twenty-four (62%) placentas showed at least one abnormality. Four placentas (4/39, 10%) showed placental staining positive for the presence of SARS-CoV-2 accompanied by a unique combination of diffuse, severe inflammatory placental changes with massive perivillous fibrin depositions, necrosis of syncytiotrophoblast, diffuse chronic intervillositis, and a specific, unprecedented CD20+ B-cell infiltration. This SARS-CoV-2 placental signature seems to correlate with foetal distress (75% vs. 15.6%, p = 0.007) but not with the severity of maternal COVID-19 disease. Conclusion: We describe a unique placental signature in pregnant patients with COVID-19, which has not been reported in a historical cohort. We show that the foetal environment can be seriously compromised by disruption of placental function due to local, devastating SARS-CoV-2 infection. Maternal clinical symptoms did not predict the severity of the SARS-CoV-2-related placental signature, resulting in a lack of adequate identification of maternal criteria for pregnancies at risk. Close foetal monitoring and pregnancy termination in case of foetal distress can prevent adverse pregnancy outcomes due to COVID-19 related placental disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The turning point of COVID-19 severity is associated with a unique circulating neutrophil gene signature
    Fuzo, Carlos A.
    Fraga-Silva, Thais F. C.
    Maruyama, Sandra R.
    Bastos, Victor A. F.
    Rogerio, Luana A.
    Takamiya, Nayore T.
    da Silva-Neto, Pedro V.
    Pimentel, Vinicius E.
    Toro, Diana M.
    Perez, Malena M.
    de Carvalho, Jonatan C. S.
    Carmona-Garcia, Ingryd
    Oliveira, Camilla N. S.
    Degiovani, Augusto M.
    Ostini, Fatima M.
    Constant, Leticia F.
    de Amorim, Alessandro P.
    Vilar, Fernando C.
    Feitosa, Marley R.
    Parra, Rogerio S.
    da Rocha, Jose J. R.
    Feres, Omar
    Gaspar, Gilberto G.
    Viana, Angelina L.
    Fernandes, Ana P. M.
    Santos, Isabel K. F. M.
    Russo, Elisa M. S.
    Cardoso, Cristina R. B.
    Sorgi, Carlos A.
    Faccioli, Lucia H.
    Bonato, Vania L. D.
    Dias-Baruffi, Marcelo
    IMMUNOLOGY, 2023, 169 (03) : 323 - 343
  • [2] Microvascular placental alterations in maternal COVID-19
    Ackermann, Maximilian
    Jonigk, Danny D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : 135 - 136
  • [3] Maternal COVID-19 exposure and placental characteristics
    Allo, Ghassan
    Sitarik, Alexandra R.
    Redding, Ashley
    Coleman, Chad M.
    Cassidy-Bushrow, Andrea E.
    Gaba, Arthur
    Straughen, Jennifer K.
    PLOS ONE, 2024, 19 (05):
  • [4] Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features
    Rebutini, Patricia Zadorosnei
    Zanchettin, Aline Cristina
    Stonoga, Emanuele Therezinha Schueda
    Pra, Daniele Margarita Marani
    de Oliveira, Andre Luiz Parmegiani
    Deziderio, Felipe da Silva
    Fonseca, Aline Simoneti
    Dagostini, Julio Cesar Honorio
    Hlatchuk, Elisa Carolina
    Furuie, Isabella Naomi
    Longo, Jessica da Silva
    Cavalli, Barbara Maria
    Dino, Carolina Lumi Tanaka
    Dias, Viviane Maria de Carvalho Hessel
    Percicote, Ana Paula
    Nogueira, Meri Bordignon
    Raboni, Sonia Mara
    de Carvalho, Newton Sergio
    Machado-Souza, Cleber
    de Noronha, Lucia
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Clinical signs, symptoms, and severity of COVID-19 in patients with rheumatic diseases during the COVID-19 epidemic
    Salesi, Mansour
    Sedarat, Maryam
    IMMUNOPATHOLOGIA PERSA, 2024, 10 (01):
  • [6] Impaired interferon signature in severe COVID-19
    Gruber, Conor
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (6) : 353 - 353
  • [7] Validating a Proteomic Signature of Severe COVID-19
    Cosgriff, Christopher V.
    Miano, Todd A.
    Mathew, Divij
    Huang, Alexander C.
    Giannini, Heather M.
    Kuri-Cervantes, Leticia
    Pampena, M. Betina
    Ittner, Caroline A. G.
    Weisman, Ariel R.
    Agyekum, Roseline S.
    Dunn, Thomas G.
    Oniyide, Oluwatosin
    Turner, Alexandra P.
    D'Andrea, Kurt
    Adamski, Sharon
    Greenplate, Allison R.
    Anderson, Brian J.
    Harhay, Michael O.
    Jones, Tiffanie K.
    Reilly, John P.
    Mangalmurti, Nilam S.
    Shashaty, Michael G. S.
    Betts, Michael R.
    Wherry, E. John
    Meyer, Nuala J.
    CRITICAL CARE EXPLORATIONS, 2022, 4 (12) : E0800
  • [8] Impaired interferon signature in severe COVID-19
    Conor Gruber
    Nature Reviews Immunology, 2020, 20 : 353 - 353
  • [9] COVID-19: A complex disease with a unique metabolic signature
    Ghini, Veronica
    Vieri, Walter
    Celli, Tommaso
    Pecchioli, Valentina
    Boccia, Nunzia
    Alonso-Vasquez, Tania
    Pelagatti, Lorenzo
    Fondi, Marco
    Luchinat, Claudio
    Bertini, Laura
    Vannucchi, Vieri
    Landini, Giancarlo
    Turano, Paola
    PLOS PATHOGENS, 2023, 19 (11)
  • [10] COVID-19 in Pregnancy: Maternal, Placental and Fetal Implications
    Edlow, A.
    BIRTH DEFECTS RESEARCH, 2023, 115 (08): : 843 - 843